课题基金 / 基金详情

Breathprinting as a window into gut microbiome chemoecology

Breathprinting as a window into gut microbiome chemoecology
呼吸印迹是了解肠道微生物组化学生态学的窗口
批准号:
10512356
负责人:
Andrew Leon Kau
金额:
$73.47万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-01 至 2027-06-30

项目摘要

项目成果

Andrew Leon Kau的其他基金

相似基金

相关文献

中文摘要
翻译
项目总结
英文摘要
PROJECT SUMMARY The gut microbiome has a profound effect on human health by influencing the development of the immune system, producing bioactive metabolites and directly aiding in the processing of food. Changes in the composition and metabolism of the gut microbial community has been associated with a wide array of human diseases, including malnutrition, auto-immunity, and even neurological function. A central aspiration of gut microbiome research is to identify individuals with abnormalities in gut microbial composition in order to intervene therapeutically. However, a major limitation is that it is logistically challenging to evaluate gut microbial composition in a patient-care setting. The studies in this proposal will advance a novel strategy to overcome this roadblock. Based on powerful preliminary studies in germ-free mice and in humans, our central hypothesis is that the volatile composition of breath offers a dynamic representation of the composition and function of the gut microbiota. We will test this hypothesis by evaluating the association between breath, gut bacterial species, and microbial metabolic functions (Aim 1). In addition, we will use two unique clinical cohorts of infants to determine how the breath volatile profile changes dynamically with changes in gut microbial community composition (Aim 2). Together, our studies will not only advance our fundamental understanding of the spectrum of breath volatiles that arise from microbial metabolism, but will also be a critical first step in determining how “breathalyzer” diagnostics of gut health can be applied clinically.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Harnessing Antibody Responses to Prevent and Treat Urinary Tract Infections
  • 批准号:
    10523527
  • 项目类别:
  • 资助金额:
    $62.77万
  • 财政年份:
    2021
  • 负责人:
    Andrew Leon Kau
  • 依托单位:
Harnessing Antibody Responses to Prevent and Treat Urinary Tract Infections
  • 批准号:
    10344461
  • 项目类别:
  • 资助金额:
    $63.03万
  • 财政年份:
    2021
  • 负责人:
    Andrew Leon Kau
  • 依托单位:
Microbial Origin of Breath Volatile Metabolites
  • 批准号:
    10171781
  • 项目类别:
  • 资助金额:
    $20.84万
  • 财政年份:
    2020
  • 负责人:
    Andrew Leon Kau
  • 依托单位:
Microbial Origin of Breath Volatile Metabolites
  • 批准号:
    10043038
  • 项目类别:
  • 资助金额:
    $26.45万
  • 财政年份:
    2020
  • 负责人:
    Andrew Leon Kau
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: